$1458.22
14.721.02%
마지막 업데이트: Nov 16, 10:40 AM

The average analyst price target for Eli Lilly is $1,382.11, 5.2% below the current price. Of 22 analysts, 21 rate it Buy and 1 Hold. Targets range from $830 to $1,700. The latest change came on Nov 16, 2026, when Barclays raised its price target on Eli Lilly from $1,400 to $1,550 and kept an Overweight rating.
Price Target Range — 9 Quarters
Analyst Consensus — 22 Analysts
Rating Trend — Last 9 Months